JAMM Therapeutics
JAMM Therapeutics is a drug discovery company developing small molecule modulators for the treatment of systemic lupus erythematosus (SLE).
JAMM Therapeutics is a business in biopharma, biotechnology, therapeutics based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA), founded in 2019.
As a business in biopharma, biotechnology, therapeutics, JAMM Therapeutics is listed here with the public details available about it.
The company is recorded as being based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA).
The company is listed at the Seed stage of development.
The company reports a headcount in the c_00001_00010 range.
| Sector | Biopharma, Biotechnology, Therapeutics |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) |
| Founded | 2019 |
| Employees | c_00001_00010 |
| Stage | seed |
Website: www.jammtx.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account